MENLO PARK, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced innovations to its Revio and Vega platforms ...
Zacks Investment Research on MSN
PacBio stock up on HiFi sequencing adoption for major SUDC research
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced that its HiFi whole-genome ...
MENLO PARK, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has joined the 1000 Genomes ...
Zacks Investment Research on MSN
PacBio stock dips post latest launch to expand multiomics capabilities
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, announced a new community-developed method, CiFi, ...
Zacks.com on MSN
Here's Why You Should Add PacBio Stock to Your Portfolio
PACB is gaining from product development and strong Q3 results, with Revio and Vega driving growth, though longer purchasing ...
SINGAPORE, July 12, 2023/EINPresswire.com/ -- Next Level Genomics Pte Ltd, a Singapore-based provider of advanced genomics solutions to researchers and clinician ...
Community-developed approach combines multi-contact 3C with HiFi sequencing to deliver haplotype-resolved assemblies from minimal input materialMENLO PARK, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- ...
New SPRQ-Nx chemistry designed to deliver the most complete view of the genome for less than $300 at scale MENLO PARK, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback